IT1291709B1 - Analoghi di buprenorfina aventi proprieta' analgesiche. - Google Patents

Analoghi di buprenorfina aventi proprieta' analgesiche.

Info

Publication number
IT1291709B1
IT1291709B1 IT97TO000444A ITTO970444A IT1291709B1 IT 1291709 B1 IT1291709 B1 IT 1291709B1 IT 97TO000444 A IT97TO000444 A IT 97TO000444A IT TO970444 A ITTO970444 A IT TO970444A IT 1291709 B1 IT1291709 B1 IT 1291709B1
Authority
IT
Italy
Prior art keywords
buprenorfina
analoghi
analgesic properties
analgesic
properties
Prior art date
Application number
IT97TO000444A
Other languages
English (en)
Inventor
Yong Hae Kim
Jin Kyu Park
Kwon Kim
Hee Sock Park
Original Assignee
Dong Kook Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Kook Pharm Co Ltd filed Critical Dong Kook Pharm Co Ltd
Publication of ITTO970444A0 publication Critical patent/ITTO970444A0/it
Publication of ITTO970444A1 publication Critical patent/ITTO970444A1/it
Application granted granted Critical
Publication of IT1291709B1 publication Critical patent/IT1291709B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT97TO000444A 1996-05-28 1997-05-26 Analoghi di buprenorfina aventi proprieta' analgesiche. IT1291709B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960018134A KR100204659B1 (ko) 1996-05-28 1996-05-28 신규한 부프레노핀계 진통제용 화합물

Publications (3)

Publication Number Publication Date
ITTO970444A0 ITTO970444A0 (it) 1997-05-26
ITTO970444A1 ITTO970444A1 (it) 1998-11-26
IT1291709B1 true IT1291709B1 (it) 1999-01-21

Family

ID=19459878

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97TO000444A IT1291709B1 (it) 1996-05-28 1997-05-26 Analoghi di buprenorfina aventi proprieta' analgesiche.

Country Status (8)

Country Link
US (1) US5849915A (it)
JP (1) JP2938405B2 (it)
KR (1) KR100204659B1 (it)
CN (1) CN1168377A (it)
DE (1) DE19722470C2 (it)
FR (1) FR2749305B1 (it)
GB (1) GB2313596B (it)
IT (1) IT1291709B1 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2138502C1 (ru) * 1999-03-29 1999-09-27 Закрытое акционерное общество "РМА-Фарм" Способ получения 17-циклопропилметил-6,14-эндо-этано-7-(2-гидрокси-3,3-диметилбут-2-ил)тетр агидро-17-норорипавина
CN1233645C (zh) * 2001-09-14 2005-12-28 中国人民解放军军事医学科学院毒物药物研究所 新的东罂粟碱衍生物及其医药用途
US7119100B2 (en) * 2001-09-14 2006-10-10 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences, P.L.A. China Oripavine derivatives and their uses as pharmaceuticals
US7220842B2 (en) * 2004-04-05 2007-05-22 Dade Behring Inc. Immunoassays for buprenorphine and norbuprenorphine
KR20060021542A (ko) * 2004-09-03 2006-03-08 한미약품 주식회사 부프레노르핀 유도체 및 이의 약학적으로 허용가능한 염
US8993764B2 (en) 2006-01-05 2015-03-31 Mallinckrodt Llc Use of oripavine as a starting material for buprenorphine
GB0606124D0 (en) * 2006-03-28 2006-05-03 Reckitt Benckiser Healthcare Buprenorphine derivatives and uses thereof
CN101492451B (zh) * 2008-01-24 2011-12-21 复旦大学 8α取代芳基-4,5-环氧吗啡喃衍生物或其盐、制备方法和用途
WO2009122436A2 (en) * 2008-03-31 2009-10-08 Sun Pharmaceutical Industries Ltd. An improved process for the preparation of morphinane analogues
US8269006B2 (en) * 2008-09-30 2012-09-18 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
WO2010039210A1 (en) 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the hydrogenation of opiate alkaloid derivatives
US8232398B2 (en) * 2008-09-30 2012-07-31 Mallinckrodt Llc Recycling process for increasing the yield of opiate alkaloid derivatives
US8232397B2 (en) * 2008-09-30 2012-07-31 Mallinckrodt Llc Processes for the production of buprenorphine with reduced impurity formation
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
CN102459275A (zh) * 2009-04-24 2012-05-16 布鲁克大学 制备吗啡烷和吗啡酮化合物的方法
FR2975912B1 (fr) 2011-05-30 2013-06-14 Flamel Tech Sa Composition a liberation controlee de buprenorphine
AU2012320291B2 (en) * 2011-10-03 2015-06-18 Macfarlan Smith Limited Process for preparing buprenorphine
CA2896919C (en) 2012-12-31 2019-01-29 Rhodes Technologies Process for preparing 7.beta.-substituted 6.alpha.,14.alpha.-ethenomorphinans and 7.beta.-substituted 6.alpha.,14.alpha.-ethanomorphinans
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1136214A (en) * 1965-06-15 1968-12-11 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB1116595A (en) * 1964-07-08 1968-06-06 Reckitt & Sons Ltd Codeine and morphine derivatives
PT95069B (pt) * 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
US5552406A (en) * 1994-06-17 1996-09-03 The Mclean Hospital Corporation Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists

Also Published As

Publication number Publication date
GB2313596B (en) 1998-08-05
DE19722470A1 (de) 1997-12-18
US5849915A (en) 1998-12-15
DE19722470C2 (de) 1999-05-06
ITTO970444A0 (it) 1997-05-26
JPH1059849A (ja) 1998-03-03
GB2313596A (en) 1997-12-03
CN1168377A (zh) 1997-12-24
JP2938405B2 (ja) 1999-08-23
KR100204659B1 (ko) 1999-06-15
FR2749305A1 (fr) 1997-12-05
ITTO970444A1 (it) 1998-11-26
FR2749305B1 (fr) 1999-10-22
KR970073584A (ko) 1997-12-10
GB9710996D0 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
MA23780A1 (fr) Quinazolinones 2, 8 disubstitues
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
NO992059D0 (no) 2-metoksyfenylpiperazinderivater
TR199501562A2 (tr) Tiyenopiridon'lar.
BR9709521A (pt) "3-Cianoaril-pirazóis"
NO20005551D0 (no) 2"-deoksyhygromycinderivater
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
IT1272346B (it) "accessorio di raccordo".
IT1293191B1 (it) Dispositivo d'illuminazione.
FR2716157B1 (fr) Agencement d'ancrage.
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
FR2720911B1 (fr) Caisse d'exposition-malle.
ES1041880Y (es) Puya de picador.
NO996127L (no) 13-dihydro-3'-aziridino-antracykliner
ITTO950294A0 (it) Procedimento per l'illuminazione di oggetti.
EP0685941A3 (en) Bootstrap circuit.
IT1283187B1 (it) "elettrovalvola."
ES1042496Y (es) "pilona sumible".
ES1034285Y (es) "expositor".
ES1038172Y (es) "caja-contenedor".

Legal Events

Date Code Title Description
0001 Granted